NASDAQ:PAHC Phibro Animal Health (PAHC) Stock Price, News & Analysis $33.26 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$32.92 -0.34 (-1.04%) As of 05/22/2026 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Phibro Animal Health Stock (NASDAQ:PAHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Phibro Animal Health alerts:Sign Up Key Stats Today's Range$32.74▼$34.0050-Day Range$33.26▼$59.5852-Week Range$22.51▼$60.08Volume252,119 shsAverage Volume479,083 shsMarket Capitalization$1.35 billionP/E Ratio14.27Dividend Yield1.44%Price Target$38.80Consensus RatingHold Company Overview Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being. The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products. The Animal Health segment offers an array of vaccines and pharmaceutical products targeting poultry, swine, cattle and aquaculture. Mineral Nutrition provides trace mineral supplements and premix solutions to optimize feed formulations, while Performance Products focuses on feed additives that improve nutrient utilization, gut health and production efficiency. Phibro’s products are used by producers, integrators and veterinary professionals to address disease prevention, growth promotion and regulatory compliance in modern animal agriculture. With operations spanning North America, Latin America, Europe, the Middle East, Africa and Asia-Pacific, Phibro serves customers in more than 70 countries. The company traces its roots to the mid-20th century and has grown through strategic acquisitions, internal research and global partnerships to build a comprehensive suite of animal health solutions. Under the leadership of its President and Chief Executive Officer, Norbert G. Schaefer, Phibro continues to invest in innovation, regulatory approvals and manufacturing capabilities to meet evolving industry needs and support sustainable food production worldwide.AI Generated. May Contain Errors. Read More Phibro Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks94th Percentile Overall ScorePAHC MarketRank™: Phibro Animal Health scored higher than 94% of companies evaluated by MarketBeat, and ranked 30th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingPhibro Animal Health has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no strong buy ratings, 2 buy ratings, 4 hold ratings, and 1 sell rating.Upside PotentialPhibro Animal Health has a consensus price target of $38.80, representing about 16.7% upside from its current price of $33.26.Amount of Analyst CoveragePhibro Animal Health has only been the subject of 3 research reports in the past 90 days.Read more about Phibro Animal Health's stock forecast and price target. Earnings and Valuation3.8 / 5Proj. Earnings Growth8.14% Earnings GrowthEarnings for Phibro Animal Health are expected to grow by 8.14% in the coming year, from $3.07 to $3.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phibro Animal Health is 14.27, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.03.Price to Earnings Ratio vs. SectorThe P/E ratio of Phibro Animal Health is 14.27, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.01.Price to Earnings Growth RatioPhibro Animal Health has a PEG Ratio of 0.50. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioPhibro Animal Health has a P/B Ratio of 3.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Phibro Animal Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.01% of the float of Phibro Animal Health has been sold short.Short Interest Ratio / Days to CoverPhibro Animal Health has a short interest ratio ("days to cover") of 5.14.Change versus previous monthShort interest in Phibro Animal Health has recently decreased by 2.54%, indicating that investor sentiment is improving. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldPhibro Animal Health pays a meaningful dividend of 1.44%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthPhibro Animal Health does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Phibro Animal Health is 20.60%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 14.46% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.Read more about Phibro Animal Health's dividend. News and Social Media3.6 / 5News Sentiment0.68 News SentimentPhibro Animal Health has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Phibro Animal Health this week, compared to 6 articles on an average week.Search Interest6 people have searched for PAHC on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Phibro Animal Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,395,532.00 in company stock.Percentage Held by Insiders50.13% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Phibro Animal Health's insider trading history. Receive PAHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PAHC Stock News HeadlinesPhibro's CEO transition puts this insider sale in contextMay 24 at 9:19 AM | finance.yahoo.com1 Russell 2000 Stock with Promising Prospects and 2 We Brush OffMay 23 at 7:59 AM | finance.yahoo.comThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.May 25 at 1:00 AM | Behind the Markets (Ad)Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws ConferenceMay 21, 2026 | businesswire.comPhibro Animal Health Corporation (PAHC) Price Target Cut to $44 by Citi Amid Sector PressureMay 20, 2026 | insidermonkey.comPhibro Animal Health (PAHC): Buy, sell, or hold post Q1 earnings?May 15, 2026 | msn.comPhibro Animal Health Corporation (PAHC) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13, 2026 | seekingalpha.comPhibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 4,528 SharesMay 8, 2026 | insidertrades.comSee More Headlines PAHC Stock Analysis - Frequently Asked Questions How have PAHC shares performed this year? Phibro Animal Health's stock was trading at $37.36 on January 1st, 2026. Since then, PAHC shares have decreased by 11.0% and is now trading at $33.26. How were Phibro Animal Health's earnings last quarter? Phibro Animal Health Corporation (NASDAQ:PAHC) issued its earnings results on Wednesday, May, 6th. The company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.72 by $0.04. The company earned $383.54 million during the quarter, compared to analyst estimates of $367.02 million. Phibro Animal Health had a net margin of 6.35% and a trailing twelve-month return on equity of 37.14%. Read the conference call transcript. When did Phibro Animal Health IPO? Phibro Animal Health (PAHC) raised $217 million in an initial public offering (IPO) on Friday, April 11th 2014. The company issued 12,745,392 shares at $16.00-$18.00 per share. Who are Phibro Animal Health's major shareholders? Top institutional shareholders of Phibro Animal Health include Renaissance Technologies LLC (1.42%), Dimensional Fund Advisors LP (1.25%), Allspring Global Investments Holdings LLC (0.71%) and Ranger Investment Management L.P. (0.69%). Insiders that own company stock include Jack Bendheim and E Thomas Corcoran. View institutional ownership trends. How do I buy shares of Phibro Animal Health? Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Phibro Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Solid Power (SLDP), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), AT&T (T) and Advanced Micro Devices (AMD). Company Calendar Record date for 3/25 Dividend3/04/2026Ex-Dividend for 3/25 Dividend3/04/2026Dividend Payable3/25/2026Last Earnings5/06/2026Today5/25/2026Stifel Jaws & Paws Conference 20265/27/2026Record date for 6/24 Dividend6/03/2026Ex-Dividend for 6/24 Dividend6/03/2026Dividend Payable6/24/2026Next Earnings (Confirmed)6/30/2026Fiscal Year End6/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, PAHC's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:PAHC CIK1069899 Webwww.pahc.com Phone(201) 329-7300Fax201-329-7399Employees2,475Year Founded1946Price Target and Rating Average Price Target for Phibro Animal Health$38.80 High Price Target$50.00 Low Price Target$24.00 Potential Upside/Downside+16.7%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)$2.33 Trailing P/E Ratio14.27 Forward P/E Ratio10.83 P/E Growth0.5Net Income$48.26 million Net Margins6.35% Pretax Margin8.59% Return on Equity37.14% Return on Assets8.57% Debt Debt-to-Equity Ratio1.97 Current Ratio3.17 Quick Ratio1.26 Sales & Book Value Annual Sales$1.30 billion Price / Sales1.04 Cash Flow$3.27 per share Price / Cash Flow10.17 Book Value$8.92 per share Price / Book3.73Miscellaneous Outstanding Shares40,560,000Free Float20,230,000Market Cap$1.35 billion OptionableOptionable Beta0.61 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:PAHC) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
